Related references
Note: Only part of the references are listed.Correlation Between the Crohn's Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn's Disease Severity
Severine Vermeire et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy
C. Loras et al.
GUT (2010)
Prevalence of Hepatitis B and C and Risk Factors for Nonvaccination in Inflammatory Bowel Disease Patients in Northeast France
Jean-Baptiste Chevaux et al.
INFLAMMATORY BOWEL DISEASES (2010)
Inflammatory bowel disease and hepatitis B and C in Western Balkans: A referral centre study and review of the literature
Konstantinos H. Katsanos et al.
JOURNAL OF CROHNS & COLITIS (2010)
Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease
M. J. Shale et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study
Carme Loras et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease
Matthew J. Shale
BRITISH MEDICAL BULLETIN (2009)
Hepatitis C Virus and Inflammatory Bowel Disease
Todd L. Horn et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Inflammatory bowel disease and hepatitis B and C
J. -B. Chevaux et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2009)
Diagnosis, Management, and Treatment of Hepatitis C: An Update
Marc G. Ghany et al.
HEPATOLOGY (2009)
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: Meta-analysis of placebo-controlled trials
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Risk factors for opportunistic infections in patients with inflammatory bowel disease
Murat Toruner et al.
GASTROENTEROLOGY (2008)
Use of the Noninvasive Components of the Mayo Score to Assess Clinical Response in Ulcerative Colitis
James D. Lewis et al.
INFLAMMATORY BOWEL DISEASES (2008)
Successful treatment of chronic hepatitis C with pegylated interferon, ribavirin, and infliximab in a patient with Crohn's disease
Manal F. Abdelmalek et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus
H. Marotte et al.
RHEUMATOLOGY (2007)
How to modulate inflammatory cytokines in liver diseases
Herbert Tilg et al.
LIVER INTERNATIONAL (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study
NN Zein
JOURNAL OF HEPATOLOGY (2005)
Diagnosis, management, and treatment of hepatitis C
DB Strader et al.
HEPATOLOGY (2004)
Pneumocystis carinii pneumonia during maintenance anti-tumor necrosis factor-α therapy with infliximab for Crohn's disease
FS Velayos et al.
INFLAMMATORY BOWEL DISEASES (2004)
Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection
LH Calabrese et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection
JR Peterson et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Immunomodulatory drugs in Crohn's disease patients with hepatitis B or C virus infection
L Biancone et al.
GASTROENTEROLOGY (2002)
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
WJ Sandborn et al.
GASTROENTEROLOGY (2001)
Hepatitis B and C virus infection in Crohn's disease
L Biancone et al.
INFLAMMATORY BOWEL DISEASES (2001)
Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection
S Campbell et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2001)